(19)

(11)

EP 4 824 041 A1

(12)

(43) Date of publication: 21.10.2026 Bulletin 2026/43 (21) Application number: 24901861.5 (22) Date of filing: 12.12.2024

(51) International Patent Classification (IPC):  C07D 209/16(2006.01) A61K 31/4045(2006.01) A61P 25/24(2006.01) A61K 31/485(2006.01) A61P 25/00(2006.01) C07D 221/28(2006.01) (52) Cooperative Patent Classification (CPC): A61K 31/4045; A61P 25/00; A61P 25/24; C07D 209/16; A61K 45/06 (86) International application number: PCT/CA2024/051651 (87) International publication number: WO 2025/123137 (19.06.2025 Gazette 2025/25)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA Designated Validation States: GE KH MA MD TN (30) Priority: 15.12.2023 US 202363610614 P (71) Applicant: 10763942 CANADA INC. (DBA. PURMINDS NEUROPHARMA) Bolton, Ontario L7E 1J9 (CA)	(72) Inventor: KOZIKOWSKI, Alan P. Wallace, Michigan 49893 (US) (74) Representative: Aera A/S  Niels Hemmingsens Gade 10, 5th Floor 1153 Copenhagen K 1153 Copenhagen K (DK)